merz radiesse (+) lidocaine injectable implant
merz asia pacific pte. ltd. - general & plastic surgery - radiesse® (+) lidocaine injectable implant is indicated for plastic / reconstructive procedures, including deep dermal and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands.
merz radiesse injectable implant
merz asia pacific pte. ltd. - general & plastic surgery - radiesse® injectable implant is indicated for hand augmentation to correct volume loss in the dorsum of the hands. radiesse® injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.
xeomin powder for solution
merz pharmaceuticals gmbh - incobotulinumtoxina - powder for solution - 100unit - incobotulinumtoxina 100unit - other miscellaneous therapeutic agents
xeomin powder for solution
merz pharmaceuticals gmbh - incobotulinumtoxina - powder for solution - 50unit - incobotulinumtoxina 50unit - other miscellaneous therapeutic agents
xeomin cosmetic powder for solution
merz pharmaceuticals gmbh - incobotulinumtoxina - powder for solution - 100unit - incobotulinumtoxina 100unit - other miscellaneous therapeutic agents
xeomin- incobotulinumtoxina injection, powder, lyophilized, for solution
merz pharmaceuticals, llc - botulinum toxin type a (unii: e211kpy694) (botulinum toxin type a - unii:e211kpy694) - botulinum toxin type a 50 [usp'u] - xeomin is indicated for the treatment of chronic sialorrhea in patients 2 years of age and older. upper limb spasticity in adult patients xeomin is indicated for the treatment of upper limb spasticity in adult patients. upper limb spasticity in pediatric patients, excluding spasticity caused by cerebral palsy xeomin is indicated for the treatment of upper limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. xeomin is indicated for the treatment of cervical dystonia in adult patients. xeomin is indicated for the treatment of blepharospasm in adult patients. xeomin is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. xeomin is contraindicated in patients with: - known hypersensitivity to any botulinum toxin product or to any of the components in the formulation [see warnings and precautions (5.3) and description (11)] . - infection at t
hepa-merz infusion concentrate 0.5g/ml
merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - concentrate for solution for infusion - l-ornithine 5 g/ml l-aspartate 5 g/ml - bile and liver therapy
hepa-merz granulate
merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - l, ornithine, aspartate - granules for oral solution - l-ornithine 3 g/5g l-aspartate 3 g/5g - bile and liver therapy
pk merz infusion 0.4mg/ml
merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - amantadine sulfate - solution for infusion - amantadine sulfate 0.4 mg/ml - anti-parkinson drugs
pk-merz 100mg film-coated tablets
merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - amantadine sulfate - film-coated tablet - amantadine sulfate 100 mg - anti-parkinson drugs